你即將離開本站

並前往https://scrip.pharmaintelligence.informa.com/SC146307/BMSs-Revlimid-Loss-Of-Exclusivity-Is-Not-As-Bad-As-Expected-But-Not-For-Long

BMS's Revlimid Loss Of Exclusivity Is Not As Bad As Expected ...

The company credited generics' late market entry, but that benefit is not expected to last; the firm lowered guidance for annual sales of ...

確定！ 回上一頁

查詢 「Not as expected」的人也找了：

  1. not expected中文
    2.
  2. Expected
    3.